Kewaunee Scientific Corp.
- KEQU ยท Nasdaq
- Laboratory Apparatus & Furniture
- Statesville, NC
- 1,231 employees
- CIK 0000055529
Updated from SEC filings through
Top things to know
Executives
-
Thomas David Hull Iii President & CEO 4, 2026-07-02 -
Donald T. Gardner III Chief Financial Officer 4, 2026-07-02 -
Elizabeth D. Phillips SVP, People & Culture 4, 2026-07-02 -
Mandar Ranade SVP, IT & Engineering 4, 2026-07-02 -
Ryan S. Noble SVP, Sales & Marketing Dev 4, 2026-07-02 - Douglas J. Batdorff SVP, Manufacturing Operations 4, 2026-07-02
What leadership is saying
“I am pleased with Kewaunee's performance during the first quarter and, importantly, with the continued execution of our strategy”
Earnings press release (8-K Ex. 99.1), filed September 9, 2026
Kewaunee Scientific Corp is a U.S. public company in laboratory apparatus & furniture (SIC 3821), headquartered in Statesville, NC. It trades as KEQU on Nasdaq. Revenue was $282M in the fiscal year ending April 30, 2026, +17.3% from the year before. It reported about 1,231 employees. Thomas David Hull Iii is President & CEO.
Five-year financials
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $282M 10-K, 2026-06-26 | $240M 10-K, 2026-06-26 | $204M 10-K, 2025-07-02 | $219M 10-K, 2024-06-28 | $169M 10-K, 2023-06-30 |
| Operating income | $16.7M 10-K, 2026-06-26 | $17.8M 10-K, 2026-06-26 | $18.3M 10-K, 2025-07-02 | $5.4M 10-K, 2024-06-28 | -$2.6M 10-K, 2023-06-30 |
| SG&A | Not on file | Not on file | Not on file | Not on file | Not on file |
| Net income | $9.6M 10-K, 2026-06-26 | $11.4M 10-K, 2026-06-26 | $18.8M 10-K, 2025-07-02 | $738K 10-K, 2024-06-28 | -$6.1M 10-K, 2023-06-30 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| | President & CEO | 4, 2026-07-02 |
| | Chief Financial Officer | 4, 2026-07-02 |
| Douglas Batdorff | Named in proxy bio: Vice President of Manufacturing Operations | DEF 14A, 2026-07-07 |
| | SVP, People & Culture | 4, 2026-07-02 |
| CIO, Senior Vice President of Information Technology & Product Engineering at Kewaunee Scientific Corp. | SVP, IT & Engineering | 4, 2026-07-02 |
| Senior Vice President of Sales and Marketing at Kewaunee Scientific Corp. | SVP, Sales & Marketing Dev | 4, 2026-07-02 |
| Douglas J. Batdorff | SVP, Manufacturing Operations | 4, 2026-07-02 |
| David S. Rhind | Board member (per proxy) bio: Director | DEF 14A, 2026-07-07 |
| Donald F. Shaw | Board member (per proxy) bio: Director | DEF 14A, 2026-07-07 |
| J. JETTE CAMPBELL | Board member (per proxy) bio: director | DEF 14A, 2026-07-07 |
| John D. Russell | Board member (per proxy) bio: Director nominee | DEF 14A, 2026-07-07 |
| Keith M. Gehl | Board member (per proxy) bio: Director | DEF 14A, 2026-07-07 |
| MARGARET B. PYLE | Board member (per proxy) bio: director | DEF 14A, 2026-07-07 |
What Kewaunee Scientific Corp does
Kewaunee Scientific Corporation (the "Company") was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970. Our principal business is the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Our products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Shares and governance
| Shares outstanding | 2.9 million (as of September 8, 2026) | 10-Q, September 11, 2026 |
|---|---|---|
| Public float | $70.1M (as of October 31, 2025) | 10-K, June 26, 2026 |
| Reportable segments | 2 (period ending July 31, 2026) | 10-Q, September 11, 2026 |
| Latest proxy statement | Meeting August 26, 2026 (filed July 7, 2026) | DEF 14A, July 7, 2026 |
| Auditor | Forvis Mazars, LLP (Raleigh, NC) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| January 7, 2026 | Thomas David Hull Iii President, CEO | Sale | 2,177 | $82K | Form 4, January 8, 2026 |
| January 6, 2026 | Donald T. Gardner III Chief Financial Officer | Sale | 2,000 | $75K | Form 4, January 7, 2026 |
| December 31, 2025 | Thomas David Hull Iii President, CEO | Sale | 658 | $25K | Form 4, January 2, 2026 |
| December 29, 2025 | Thomas David Hull Iii President, CEO | Sale | 884 | $34K | Form 4, December 31, 2025 |
| December 22, 2025 | Thomas David Hull Iii President, CEO | Sale | 1,000 | $39K | Form 4, December 23, 2025 |
| December 17, 2025 | Thomas David Hull Iii President, CEO | Sale | 1,000 | $39K | Form 4, December 17, 2025 |
| October 9, 2025 | Donald T. Gardner III Chief Financial Officer | Sale | 3,000 | $128K | Form 4, October 10, 2025 |
| October 2, 2025 | Elizabeth D. Phillips VP - Human Resources | Sale | 6,880 | $297K | Form 4, October 2, 2025 |
Recent 8-K events
- 8-K filed 2026-11-02
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-09-09
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-27
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-08-26
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-25
- Item 8.01 Other events
- 8-K filed 2026-06-23
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-06-10
- Item 8.01 Other events
- 8-K filed 2026-03-11
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-02-25
- Item 8.01 Other events
- 8-K filed 2025-12-10
- Item 2.02 Results of operations and financial condition (earnings release)
Frequently asked questions about Kewaunee Scientific Corp
- What does Kewaunee Scientific Corp do?
- In its own words, from Item 1 of its 10-K: "Kewaunee Scientific Corporation (the "Company") was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970. Our principal business is the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Our products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks."
- What is Kewaunee Scientific Corp's revenue?
- $282M for the fiscal year ending April 30, 2026, from its 10-K filed June 26, 2026.
- Is Kewaunee Scientific Corp profitable?
- Kewaunee Scientific Corp reported net income of $9.6M for the fiscal year ending April 30, 2026.
- How many employees does Kewaunee Scientific Corp have?
- About 1,231 as of April 30, 2026, as stated in its annual report.
- Who is the CEO of Kewaunee Scientific Corp?
- Thomas David Hull Iii, President & CEO, as named in a 4 filed July 2, 2026.
- Who is the CFO of Kewaunee Scientific Corp?
- Donald T. Gardner III, Chief Financial Officer, as named in a 4 filed July 2, 2026.
- Where is Kewaunee Scientific Corp headquartered?
- Statesville, NC.
- What is Kewaunee Scientific Corp's stock ticker?
- KEQU on Nasdaq.
- What industry is Kewaunee Scientific Corp in?
- Laboratory Apparatus & Furniture, SIC code 3821.
- What is Kewaunee Scientific Corp's website?
- kewaunee.com.
- When does Kewaunee Scientific Corp report earnings next?
- December 9, 2026. Source: pg_future_events.
- Is Kewaunee Scientific Corp a public company?
- Yes. Kewaunee Scientific Corp files with the SEC under CIK 0000055529 and trades as KEQU.
- Who audits Kewaunee Scientific Corp?
- Forvis Mazars, LLP, Raleigh, NC, as named in its latest annual report (10-K).
- How many shares of Kewaunee Scientific Corp are outstanding?
- 2.9 million shares as of September 8, 2026, from its 10-Q filed September 11, 2026.
- What is Kewaunee Scientific Corp's public float?
- $70.1M as of October 31, 2025, as reported on the cover of its 10-K filed June 26, 2026.
- How many business segments does Kewaunee Scientific Corp report?
- 2 reportable segments for the period ending July 31, 2026, from its 10-Q filed September 11, 2026.
- When is Kewaunee Scientific Corp's annual shareholder meeting?
- August 26, 2026, per its proxy statement (DEF 14A) filed July 7, 2026.
- Have Kewaunee Scientific Corp insiders traded stock recently?
- Since July 24, 2025, officers and directors reported 13 open-market sales worth about $1.2M and 0 purchases on Forms 4 and 5. The most recent: Thomas David Hull Iii (President, CEO) sold 2,177 shares on January 7, 2026.